Exclusive gold-yield token deal for BioSig Technologies (NASDAQ: BSGM)

Rhea-AI Filing Summary

BioSig Technologies, Inc. entered a three-year Tokenized Yield Partnership Agreement with Monetary Metals & Co. to create and distribute blockchain-based products that tokenize yield from precious-metal lease and bond programs. The partnership includes mutual exclusivity for tokenizing yield from precious-metal leases, subject to volume-based performance thresholds and a ninety-day cure period if supply falls short. Each quarter, BioSig must supply at least 10% of qualifying leased ounces, while Monetary Metals will offer at least 90% of the gold under management supplied by BioSig as Passing Leases. BioSig will receive discounted fees and quarterly cash rebates on gold purchases, plus a quarterly revenue share of 0.35% to 0.50% on supplied gold deployed in Passing Leases, and will own the intellectual property for the tokenized yield products.

Insights

Fintech and Capital Markets Analyst

BioSig secures an exclusive, IP-heavy deal to tokenize gold lease yields.

BioSig Technologies has signed a multi-year partnership with Monetary Metals to design and launch blockchain-based products that tokenize yield from precious-metal lease and bond programs. The agreement is exclusive for at least three years for this niche, tying BioSig to Monetary Metals’ gold leasing platform while reserving tokenization rights for BioSig.

Economic terms combine discounted fees on gold purchases with quarterly cash rebates and a revenue share between 0.35% and 0.50% on Passing Leases, aligned to total kilograms leased. This structure links BioSig’s upside directly to the volume and quality of gold leases meeting specified insurance, yield, and compliance criteria, without an obligation to commit capital if exclusivity is lost.

Control of new intellectual property from tokenized yield products rests solely with BioSig, while Monetary Metals retains IP over its lease and bond products. Future disclosures in company reports may clarify how much lease volume is achieved under the quarterly 10% supply requirement and how meaningful the associated fee discounts and revenue share become over the initial three-year term.

8-K Event Classification

3 items: 1.01, 8.01, 9.01

3 items

Item 1.01 Entry into a Material Definitive Agreement Business

The company signed a significant contract such as a merger agreement, credit facility, or major partnership.

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

What did BioSig Technologies (BSGM) announce in this 8-K?

BioSig Technologies entered a Tokenized Yield Partnership Agreement with Monetary Metals & Co. to design, launch, and distribute blockchain-based products that tokenize yield from precious-metal lease and bond programs.

How long does the BioSig–Monetary Metals tokenized yield partnership last?

The agreement commenced on September 8, 2025, has an initial three-year term, and then automatically renews for one-year periods unless terminated under its terms.

What are the exclusivity terms in the BioSig (BSGM) and Monetary Metals partnership?

For at least three years, Monetary Metals will not partner with others to tokenize yield or other financial attributes of its precious-metal lease or bond products, and BioSig will not partner with third parties to tokenize yield from precious-metal leases, subject to volume-based performance conditions.

What performance obligations does BioSig have under the tokenized yield agreement?

Each quarter, BioSig must supply at least 10% of the total leased ounces presented by Monetary Metals that meet insurance, yield of at least 3% per annum after origination fees, and sanctions-related criteria, to retain exclusivity, with a ninety-day cure period for shortfalls.

How is BioSig compensated in the Monetary Metals tokenized yield partnership?

BioSig will receive a discounted fee and quarterly cash rebate on gold purchases based on a tiered fee schedule ranging from 0.75% to 0.20% of aggregate quarterly purchase volume, plus a quarterly revenue share between 0.35% and 0.50% on company-supplied gold deployed in Passing Leases.

Who owns the intellectual property from the tokenized yield products in the BioSig partnership?

All intellectual property arising from the design and development of the tokenized yield products will be owned exclusively by BioSig Technologies, while Monetary Metals retains exclusive ownership of IP related to its lease and bond products.

Can the BioSig–Monetary Metals tokenized yield agreement be terminated early?

Either party may terminate the agreement for convenience on six months’ notice or for customary breach and insolvency events, though certain exclusivity obligations survive for a minimum of three years.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding 8-K Material Events →

Accepted by SEC EDGAR 09/08/2025 - 03:59 PM Learn about SEC filing dates

false 0001530766 0001530766 2025-09-08 2025-09-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 8, 2025

BioSig Technologies, Inc.

(Exact name of registrant as specified in its charter)

Delaware		001-38659		26-4333375
(State or other jurisdiction		(Commission		(IRS Employer
of incorporation)		File Number)		Identification No.)

12424 Wilshire Blvd., Ste 745 Los Angeles, California		90025
(Address of principal executive offices)		(Zip Code)

(203) 409-5444

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of exchange on which registered
Common Stock, par value $0.001 per share		BSGM		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01 Entry into a Material Definitive Agreement.

On September 8, 2025, BioSig Technologies, Inc. (the “Company”) entered into a Tokenized Yield Partnership Agreement (the “Agreement”) with Monetary Metals & Co. (“MM”), a Delaware corporation. The Agreement establishes an exclusive, multi-year strategic partnership aimed at designing, launching, and distributing blockchain-based financial products that tokenize the yield generated from MM’s precious-metal lease and bond programs.

The Agreement commenced on September 8, 2025, and continues for an initial term of three years, subject to automatic one-year renewal periods unless terminated in accordance with its terms. For at least three years, MM has agreed not to engage with any other party to tokenize the yield or other financial attributes of its precious-metal lease or bond products, and the Company has agreed not to partner with any third party to tokenize yield derived from precious-metal leases, in each case subject to specified volume-based performance conditions.

Each quarter, the Company must supply at least 10% of the total leased ounces presented by MM that (a) meet the minimum insurance standards as set forth in the Agreement; (b) generates a net yield of at least 3% per annum after origination fees, and (c) does not involve a Prohibited Person (as defined in the Agreement) or an ultimate borrower located in a Restricted Nation (as defined in the Agreement) (“Passing Leases”). MM must offer Passing Leases in an amount equal to at least 90% of the gold under management supplied by the Company. The Company’s obligation to meet such quarterly supply thresholds is a condition to the retention of exclusivity under the Agreement, and failure to do so, after application of the ninety-day cure period for any alleged shortfall, will result in the loss of exclusivity but will not otherwise obligate the Company to commit capital or continue participation.

MM will provide the Company with a discounted fee and quarterly cash rebate on the Company gold purchases based on a tiered fee schedule ranging from 0.75% to 0.20% of aggregate quarterly purchase volume. MM will pay the Company a quarterly revenue share on the Company supplied gold deployed in Passing Leases, on a sliding scale from 0.35% to 0.50%, depending on total kilograms leased.

All intellectual property arising from the design and development of the tokenized yield products will be owned exclusively by the Company, while MM retains exclusive ownership of intellectual property related to its lease and bond products.

Either party may terminate for convenience on six months’ notice or for customary breach and insolvency events. Certain exclusivity obligations survive for a minimum of three years.

The foregoing summary of the Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 8.01 Other Events.

On September 8, 2025, the Company issued a press release announcing the execution of the Agreement.

A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number		Description
10.1		Tokenized Yield Partnership Agreement, dated as of September 8, 2025, between BioSig Technologies, Inc. and Monetary Metals & Co.
99.1		Press Release, dated September 8, 2025
104		Cover Page Interactive Data File (formatted as Inline XBRL)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	BIOSIG TECHNOLOGIES, INC.
Date: September 8, 2025	By:	/s/ Karl Henry McPhie
	Name:	Karl Henry McPhie
	Title:	Chief Executive Officer